Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy - A multicenter cohort study.

[1]  J. Weitz,et al.  Prognostic relevance of preoperative bilirubin-adjusted serum carbohydrate antigen 19-9 in a multicenter subset analysis of 179 patients with distal cholangiocarcinoma. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[2]  D. Aust,et al.  The pathohistological subtype strongly predicts survival in patients with ampullary carcinoma , 2019, Scientific Reports.

[3]  R. Salem,et al.  Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma. , 2019, JAMA surgery.

[4]  D. Adler,et al.  Demographics, tumor characteristics, treatment, and clinical outcomes of patients with ampullary cancer: a Surveillance, Epidemiology, and End Results (SEER) cohort study. , 2019, Minerva gastroenterologica e dietologica.

[5]  P. Laurent-Puig,et al.  Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO study , 2019, British Journal of Cancer.

[6]  H. Zeh,et al.  Incidence and comparative outcomes of periampullary cancer: A population‐based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012 , 2018, Journal of surgical oncology.

[7]  N. Jamieson,et al.  Histopathologic Predictors of Survival and Recurrence in Resected Ampullary Adenocarcinoma , 2019, Annals of surgery.

[8]  D. Shen,et al.  Identification of ampullary carcinoma mixed subtype using a panel of six antibodies and its clinical significance , 2018, Journal of surgical oncology.

[9]  D. Nagorney,et al.  Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  M. Choti,et al.  Association of Adjuvant Therapy with Improved Survival in Ampullary Cancer: A National Cohort Study , 2018, Journal of Gastrointestinal Surgery.

[11]  S. Kamarajah.  Adjuvant radiotherapy following pancreaticoduodenectomy for ampullary adenocarcinoma improves survival in node-positive patients: a propensity score analysis , 2018, Clinical and Translational Oncology.

[12]  T. Price,et al.  Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer , 2017, World journal of gastrointestinal oncology.

[13]  M. Abu Hilal,et al.  Elderly patients have similar short term outcomes and five-year survival compared to younger patients after pancreaticoduodenectomy. , 2017, International journal of surgery.

[14]  R. Grützmann,et al.  Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study , 2017, Langenbeck's Archives of Surgery.

[15]  D. Shibata,et al.  Management and outcomes following pancreaticoduodenectomy for ampullary adenocarcinoma. , 2017, American journal of surgery.

[16]  J. Wong,et al.  Clinicopathologic and survival analysis of resected ampullary adenocarcinoma , 2016, Journal of surgical oncology.

[17]  A. Scarpa,et al.  Characterization of various cell lines from different ampullary cancer subtypes and cancer associated fibroblast-mediated responses , 2016, BMC Cancer.

[18]  J. Cameron,et al.  Two thousand consecutive pancreaticoduodenectomies. , 2015, Journal of the American College of Surgeons.

[19]  M. Nagino,et al.  Prognostic impact of lymph node metastasis in distal cholangiocarcinoma , 2015, The British journal of surgery.

[20]  Shung-Haur Yang,et al.  Concordance of Carcinoembryonic Antigen Ratio and Response Evaluation Criteria in Solid Tumors as Prognostic Surrogate Indicators of Metastatic Colorectal Cancer Patients Treated with Chemotherapy , 2015, Annals of Surgical Oncology.

[21]  T. Keck,et al.  Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin , 2013, BMC Cancer.

[22]  M. Büchler,et al.  Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. , 2012, JAMA.

[23]  D. Choi,et al.  Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer , 2012, Journal of surgical oncology.

[24]  P. Clavien,et al.  Ampullary cancer , 2010, Current opinion in gastroenterology.

[25]  H. Yamaue,et al.  The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma. , 2010, American journal of surgery.

[26]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[27]  M. Bloomston,et al.  Predictors of Survival in Periampullary Cancers Following Pancreaticoduodenectomy , 2010, Annals of Surgical Oncology.

[28]  K. Campbell,et al.  Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. , 2006, Surgery.

[29]  W. Kimura,et al.  Neoplastic diseases of the papilla of Vater. , 2004, Journal of hepato-biliary-pancreatic surgery.

[30]  D. Henson,et al.  Tumors of the Gallbladder, Extrahepatic Bile Ducts and Ampulla of Vater , 2000 .

[31]  Broders Ac.  Malignant neoplasia of normally situated and heterotopic lymphoid tissue and its numerical microscopic grading. , 1953 .

[32]  S. Reddy,et al.  Ampullary Cancer. , 2019, The Surgical clinics of North America.

[33]  M. Makary,et al.  2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. , 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[34]  T. Bekaii-Saab,et al.  Ampullary cancer: an overview. , 2014, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[35]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[36]  A. C. Broders.  Malignant neoplasia of normally situated and heterotopic lymphoid tissue and its numerical microscopic grading. , 1953, Texas state journal of medicine.